BillionToOne, Inc. (BLLN)
BillionToOne, Inc. (BLLN) from its SEC filings: 2025 revenue $305.1 million (+100% vs the year before), net margin 2%, free cash flow $15.7 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Services-Medical Laboratories |
| Revenue (2025) | $305.1 million |
| Revenue growth | +100% |
| Net income | $7.5 million |
| Net margin | 2.4% |
| Free cash flow | $15.7 million |
| Diluted EPS | $0.14 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +64% |
| Cash | $548.6 million |
| Long-term debt | $57.2 million |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.